Association between bisphenol exposure and polycystic ovary syndrome risk: an integrated systematic review and meta-analysis
Frontiers in Endocrinology · 2026
DOI: 10.3389/fendo.2026.1859611 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Endocrinology, 2026. Verfasst von Zongying Gui und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Ningbo No.2 Hospital, Wenzhou Medical University, Ningbo, China. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Phenols, Benzhydryl Compounds, Endocrine Disruptors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder associated with environmental endocrine-disrupting chemicals, particularly bisphenols (BPs) such as bisphenol A (BPA) and bisphenol S (BPS). BPs may disrupt reproductive and metabolic pathways through estrogenic, anti-androgenic, and obesogenic effects, contributing to the pathogenesis of PCOS. However, the epidemiological evidence remains inconsistent.
Methods
This PRISMA-guided systematic review and meta-analysis evaluated observational studies (cross-sectional, case-control, longitudinal) from PubMed and Web of Science up to December 2024. Seventeen studies involving 3, 010 women were included after screening. The quality of the studies was assessed using the Newcastle-Ottawa Scale. Standardized mean differences (SMDs) with 95% confidence intervals (CIs) were calculated using random-effects models due to high heterogeneity (I² > 50%). Subgroup analyses were conducted to explore the sources of heterogeneity.
Result
The meta-analysis revealed significant positive associations between PCOS risk and serum BPA (SMD = 1.32, 95% CI: 0.83–1.82), urinary BPA (SMD = 2.69, 95% CI: 1.41–3.97), and serum BPS (SMD = 0.26, 95% CI: 0.07–0.46). Heterogeneity was high for BPA (I² = 95–99%) but absent for BPS (I² = 0%). Sensitivity analyses excluding lower-quality studies confirmed the robustness of the findings. Subgroup analyses utilizing the Rotterdam criteria slightly attenuated the associations for BPA. Funnel plots indicated no significant publication bias.
Conclusion
Exposure to BPs, represented by BPA and BPS, was significantly associated with an increased risk of PCOS, likely mediated by endocrine disruption, metabolic dysregulation, and epigenetic mechanisms. These findings underscore the necessity for regulatory policies aimed at reducing population-level exposure to BPs, the clinical integration of BPs biomonitoring in the management of PCOS, and further research on gene-environment interactions and non-monotonic dose effects. Addressing exposure to BPs may offer novel preventive and therapeutic strategies for PCOS. Systematic Review Registration https://www.crd.york.ac.uk/prospero/ , CRD42024578174.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology, Ningbo No.2 Hospital, Wenzhou Medical University, Ningbo, China.
Zitieren
APA
Gui, Z., Lin, H., Wang, C., & Yao, Y. (2026). Association between bisphenol exposure and polycystic ovary syndrome risk: an integrated systematic review and meta-analysis. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2026.1859611
Vancouver
Gui Z, Lin H, Wang C, Yao Y. Association between bisphenol exposure and polycystic ovary syndrome risk: an integrated systematic review and meta-analysis. Frontiers in Endocrinology. 2026. doi:10.3389/fendo.2026.1859611
BibTeX
@article{Gui2026,
author = {Gui, Zongying and Lin, Huizhen and Wang, Chuhan and Yao, Yingsha},
title = {Association between bisphenol exposure and polycystic ovary syndrome risk: an integrated systematic review and meta-analysis},
journal = {Frontiers in Endocrinology},
year = {2026},
doi = {10.3389/fendo.2026.1859611}
}
EUVIMED